What is the clinical evidence from this study?

Study design: Review. Population: Atherosclerosis. Intervention: Novel biomarkers and omics technologies vs. Traditional risk factors.

What question did this study set out to answer?

This paper aims to explore novel methodologies for identifying biomarkers that enhance cardiovascular risk prediction.

May 13, 2026European Heart JournalOpen Access

Novel methodologies for biomarker discovery in atherosclerosis

View Full Paper

Ask AI

Bookmark

Design

Guideline

Authors

IHImo E. HoeferGeneral Cardiology SSSabine SteffensPreventive Cardiology MAMika Ala‐KorpelaPreventive Cardiology

Discussion

Member takes

Implication

This consensus statement outlines the current state and future directions of biomarker research, emphasizing novel -omics technologies for enhanced cardiovascular risk prediction.

Key Points

This paper aims to explore novel methodologies for identifying biomarkers that enhance cardiovascular risk prediction.
Reviewed current vascular biomarkers beyond traditional risk factors.
Analyzed emerging omics technologies, including proteomics and metabolomics.
Discussed limitations of classical biomarkers and introduced novel sources like microvesicles and micro-RNAs.
Emphasized the need for improved individual cardiovascular risk prediction using novel biomarkers.
Highlighted the role of pro-inflammatory lipid metabolites in cardiovascular health.
Promoted a conceptual shift to focus on HDL composition/function rather than just cholesterol levels.

PICO

Population

Atherosclerosis

Intervention / Comparator

Novel biomarkers and omics technologies vs Traditional risk factors

This consensus statement outlines the current state and future directions of biomarker research, emphasizing novel -omics technologies for enhanced cardiovascular risk prediction.

Cite This Study

Hoefer et al. (2015) conducted a review in Atherosclerosis. Novel biomarkers and omics technologies vs. Traditional risk factors was evaluated. Emerging omics technologies, circulating micro-RNAs, and advanced analytics like mass spectrometry offer novel pathways for biomarker discovery to improve individual cardiovascular risk prediction.

synapsesocial.com/papers/6a044202151c485067848bf2 https://doi.org/10.1093/eurheartj/ehv236

View Full Paper

Ask AI

Bookmark

Implication

This consensus statement outlines the current state and future directions of biomarker research, emphasizing novel -omics technologies for enhanced cardiovascular risk prediction.

Novel methodologies for biomarker discovery in atherosclerosis

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Novel methodologies for biomarker discovery in atherosclerosis

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Also Consider

Also Consider